首站-论文投稿智能助手
典型文献
How open is the therapeutic horizon for pancreatic cancer patients?
文献摘要:
In the nineties of the last century, it was typical for an arti- cle about pancreatic cancer to start with an introductory remark, that this malignancy is a very desperate one and that surgery is the only curative option. But it was also obvious that surgery was not really curative and most importantly, not feasible in the ma- jority of cases. In the last two decades, we observed a dramatic increase in research on pancreatic cancer (e.g. more than 65000 articles mentioning pancreatic cancer in PubMed only in the last decade), and clearly, there is scientific progress. This accounts for (i) genetically defined subtypes (for an overview on the various studies [1] ), for (ii) precursor lesions like pancreatic intraepithe- lial neoplasias (PanINs), intraductal papillary mucinous neoplasm (IPMN) and acinar-ductal metaplasia (ADM) [2] , for (iii) compre- hensive characterization of the tumor microenvironment [3] , for (iv) animal models – both genetically engineered mouse models (GEMMs) and xenotransplant systems [4] , for (v) complex in vitro systems like spheroids, organoids, complex co-cultures, chip-based 3D-models [5] , and for (vi) the impact of the microbiome [6] as well as for (vii) the metabolic implications [7] and finally, for (viii) the biomarker field which has shown progress beyond the tumor marker carbohydrate antigen 19-9 (CA19-9) [8] .
文献关键词:
作者姓名:
Holger Kalthoff
作者机构:
Institute for Experimental Cancer Research,Christian-Albrechts-University,Kiel,Germany
引用格式:
[1]Holger Kalthoff-.How open is the therapeutic horizon for pancreatic cancer patients?)[J].国际肝胆胰疾病杂志(英文版),2022(01):1-3
A类:
nineties,introductory,desperate,intraepithe,neoplasias,PanINs,GEMMs,xenotransplant,vii,viii
B类:
How,open,therapeutic,horizon,pancreatic,cancer,patients,In,last,century,was,typical,about,start,remark,that,this,malignancy,very,one,surgery,only,curative,option,But,also,obvious,really,most,importantly,feasible,jority,cases,two,decades,observed,dramatic,increase,research,more,than,articles,mentioning,clearly,there,scientific,progress,This,accounts,genetically,defined,subtypes,overview,various,studies,precursor,lesions,like,lial,intraductal,papillary,mucinous,neoplasm,IPMN,acinar,metaplasia,ADM,compre,hensive,characterization,tumor,microenvironment,animal,models,both,engineered,mouse,systems,complex,vitro,spheroids,organoids,cultures,chip,impact,microbiome,well,metabolic,implications,finally,biomarker,field,which,has,shown,beyond,carbohydrate,antigen,CA19
AB值:
0.54096
相似文献
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma
Xiao Mo;Cheng-fei Zhang;Ping Xu;Min Ding;Zhi-jie Ma;Qi Sun;Yu Liu;Hong-kai Bi;Xin Guo;Alaa Abdelatty;Chao Hu;Hao-jun Xu;Guo-ren Zhou;Yu-liang Jia;Hong-ping Xia-Sir Run Run Hospital,Nanjing Medical University,Nanjing 211166,China;School of Basic Medical Sciences&State Key Laboratory of Reproductive Medicine&Key Laboratory of Antibody Technique of National Health Commission&Jiangsu Antibody Drug Engineering Research Center,Nanjing Medical University,Nanjing 210092,China;Jiangsu Cancer Hospital&Jiangsu Institute of Cancer Research&The Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210092,China;Yijishan Hospital of Wannan Medical College,Wannan Medical College,Wuhu 241002,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。